Medical Developments International Limited (ASX: MVP) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Medical Developments International Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Medical Developments International Limited (ASX: MVP)
Latest News
Share Market News
5 things to watch on the ASX on Monday
Share Gainers
Why these 4 ASX shares have started the week with a bang
Share Gainers
Medical Developments International Ltd (ASX:MVP) shares rocket on China expansion plans
Share Market News
Should you worry when management sell shares?
Share Gainers
Why these 4 ASX shares have started the week with a bang
Share Market News
ALL ORDINARIES finishes higher Wednesday: 8 shares you missed
Share Gainers
Medical Developments International Ltd (ASX:MVP) shares storm higher on U.S. FDA update
Share Market News
REA Group Limited (ASX:REA) CEO sells $911,490 of shares, time to worry?
Share Fallers
Medical Developments International Ltd shares wobble on mixed year, U.S. uncertainty
⏸️ ASX Shares
Should you buy these healthcare shares?
52-Week Lows
Are these beaten down ASX shares in the bargain bin?
Share Fallers
Why these 4 ASX shares are ending the week in the red
Frequently Asked Questions
-
Medical Developments International has not paid a Dividend since 2019.
-
Medical Developments International Ltd listed on the ASX on 15 December 2003.
MVP ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Medical Developments International Limited
Medical Developments International Ltd (ASX: MVP) is an Australian- based pharmaceutical company. It manufactures and distributes pharmaceutical drugs covering pain management, asthma, and resuscitation, as well as medical and veterinary equipment.
The company has three business units: pharmaceuticals, medical devices, and veterinary products. The majority of its revenue comes from its pharmaceuticals segment which produces and sells the pain relief drug Penthrox within Australia, New Zealand, and the United Kingdom, as well as some sales in other countries.
